To solve this issue and improve tumor immunotherapy, a mannosylated lactoferrin nanoparticulate system (Man-LF NPs) has been developed for the co-delivery of shikonin and JQ1, an effective inhibitor of PD-L1 (142). The gene discussed is LTF; the disease is neoplasm.